Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  623 results for ""Estrogen Receptor Modulators""

Your Filters

Publication : bmc cancer
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.

  • Authors : Larsen SL; Breast Cancer Group, Unit of Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark. .; Yde CW

Subjects: Drug Resistance, Neoplasm*; Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*pharmacology ; Aurora Kinase B/Aurora Kinase B/Aurora Kinase B/*metabolism

  • Source: BMC cancer [BMC Cancer] 2015 Apr 08; Vol. 15, pp. 239. Date of Electronic Publication: 2015 Apr 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology ; Calcitriol/Calcitriol/Calcitriol/*pharmacology ; Estrogen Receptor Modulators/Estrogen Receptor Modulators/Estrogen Receptor Modulators/*pharmacology

  • Source: BMC cancer [BMC Cancer] 2014 Mar 29; Vol. 14, pp. 230. Date of Electronic Publication: 2014 Mar 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Connect Read More Add to Saved list
×
Academic Journal

Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.

  • Authors : Han W; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. ; Han MR

Subjects: Estrogens* ; Nucleic Acid Hybridization*; Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*therapeutic use CMF regimen

  • Source: BMC cancer [BMC Cancer] 2006 Apr 12; Vol. 6, pp. 92. Date of Electronic Publication: 2006 Apr 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.

Subjects: *ESTROGEN receptors; *PANCREATIC cancer; *DUCTAL carcinoma

  • Source: BMC Cancer. 10/29/2018, Vol. 18 Issue 1, p1-9. 9p. 1 Color Photograph, 5 Charts, 2 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Clinicopathological characteristics, treatment patterns and outcomes in patients with HER2-positive breast cancer based on hormone receptor status: a retrospective study.

  • Authors : Ran R; Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/mortality ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

  • Source: BMC cancer [BMC Cancer] 2024 Sep 30; Vol. 24 (1), pp. 1216. Date of Electronic Publication: 2024 Sep 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Connect Read More Add to Saved list
×
Academic Journal

PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study.

  • Authors : Ballé JK; Global Health Working Group, Institute of Medical Epidemiology, Biostatistics and Informatics, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.; Vetter M

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/mortality ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy

  • Source: BMC cancer [BMC Cancer] 2024 Sep 10; Vol. 24 (1), pp. 1127. Date of Electronic Publication: 2024 Sep 10.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).

Subjects: BREAST cancer; METASTASIS; SELECTIVE estrogen receptor modulatorsSPSS (Computer software)

  • Source: BMC Cancer; 7/5/2018, Vol. 18 Issue 1, p1-9, 9p, 5 Charts, 1 Graph

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial.

Subjects: SELECTIVE estrogen receptor modulators; BONE metastasis; PROSTATE cancer

  • Source: BMC Cancer; 11/2/2015, Vol. 15, p1-8, 8p, 1 Color Photograph, 1 Diagram, 3 Charts, 2 Graphs

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand.

Subjects: Piperazines*/Piperazines*/Piperazines*/administration & dosage ; Piperazines*/Piperazines*/Piperazines*/adverse effects ; Piperazines*/Piperazines*/Piperazines*/therapeutic use

  • Source: BMC cancer [BMC Cancer] 2024 Aug 16; Vol. 24 (1), pp. 1018. Date of Electronic Publication: 2024 Aug 16.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study.

  • Authors : Hu ZY; Medical Department of Breast Cancer, Hunan Cancer Hospital, No. 283, Tongzipo Road, Changsha, 410013, China.; Medical Department of Breast Cancer, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology

  • Source: BMC cancer [BMC Cancer] 2024 Jul 30; Vol. 24 (1), pp. 915. Date of Electronic Publication: 2024 Jul 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  623 results for ""Estrogen Receptor Modulators""